CytoSelect Cell Migration and Invasion Assay (8 um) Assay Kit

CytoSelect 96-well Cell Migration and Invasion Assay (8 um), Fluorometric, Combo Kit

Cat. Num. AAA168493

• Synonyms: CytoSelect Cell Migration and Invasion Assay (8 um); CytoSelect 96-well Cell Migration and Invasion Assay (8 um); Fluorometric; Combo Kit; CytoSelect Cell Migration and Invasion Assay (8 um) assay kit

• Preparation and Storage: Store all components at 4 degree C until their expiration dates

Testing Data

Testing Data #2

Testing Data #3

Testing Data #4

Testing Data #5

Testing Data #6

Related Product Information for CytoSelect Cell Migration and Invasion Assay (8 um) assay kit

Background: Cell migration is a highly integrated, multistep process that orchestrates embryonic morphogenesis, tissue repair and regeneration. It plays a pivotal role in the disease progression of cancer, mental retardation, atherosclerosis, and arthritis. The initial response of a cell to a migration-promoting agent is to polarize and extend protrusions in the direction of the attractant; these protrusions can consist of large, broad lamellipodia or spike-like filopodia. In either case, these protrusions are driven by actin polymerization and can be stabilized by extracellular matrix (ECM) adhesion or cell-cell interactions. The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the significant morbidity and mortality of cancers. Invasiveness requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Metastatic cells produce many proteolytic enzymes (e.g. lysosomal hydrolysates, collagenases, plasminogen activators) while the expression of certain cell surface protease receptors is also increased. CytoSelect 96-well Cell Migration and Invasion Assay Kit utilizes a polycarbonate membrane plate (8 mum pore size) or basement membrane-coated inserts to assay the migratory or invasive properties of cells. The kit does not require you to prelabel the cells with Calcein AM or remove non-migratory or non-invasive cells (i.e. cotton swabbing). Any migratory or invasive cells are first dissociated from the membrane, then lysed and detected with CyQuant GR Dye. The CytoSelect 96-well Cell Migration and Invasion Assay Kit provides a robust system for the quantitative determination of cell migration. Each assay contains sufficient reagents for the evaluation of 96 samples. The 8 mum pore size is optimal for epithelial and fibroblast cell migration. However, in the case of leukocyte chemotaxis, a smaller pore size (3 mum) is recommended.

Product Categories/Family for CytoSelect Cell Migration and Invasion Assay (8 um) assay kit

Cell Based Assays; Cell Migration; Invasion and Wound Healing; Boyden Chamber Assays; Chemotaxis/Cell Invasion Combo Kits

References

1. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR. (2003) Science 302, 1704-9.
2. Horwitz R, Webb D. (2003) Curr Biol. 13, R756-9.
3. Lauffenburger DA, Horwitz AF. (1996) Cell 84, 359-369.
1. Sharma, N. L. et al. (2014). The ETS family member GABPalpha modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 42:6256-6269.
2. Zecchini, V. et al. (2014). Nuclear ARRB1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. EMBO J. 33:1365-1382.
3. Ardiani, A. et al. (2014). Vaccine-mediated immunotherapy directed against a transcription factor driving the metastatic process. Cancer Res. 74:1945-1957.
4. Sharma, N.L. et al. (2014). The ETS family member GABPa modulates androgen receptor signaling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Res. 10.1093/nar/gku281.
5. Axlund, S.D. et al. (2010). HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Mol. Cancer Res. 8:1643-1655.
6. Alfano, R.W. et al. (2009). Matrix metalloproteinase-activated anthrax lethal toxin inhibits endothelial invasion and neovasculature formation during in vitro morphogenesis. Mol. Cancer Res. 7:452-461.
7. Eckstein, N. et al. (2008). EGFR-pathway analysis identifies amphiregulin as a key factor for cisplatin resistance of human breast cancer cells. J. Biol. Chem. 283:739-750.